{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001880","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2025-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.946258+00:00","generated_at":"2026-05-17T02:11:08.935533+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Artelo Biosciences appoints Mark Spring as CFO effective November 1, 2025","bullets":["Spring replaces Gregory Gorgas as principal financial officer and treasurer; Gorgas remains CEO.","Spring receives $250,000 base salary, 35% target bonus, and severance of 12 months base salary (18 months on change in control).","Gorgas amended agreement: severance increased to 24 months base salary and target bonus (36 months during CIC protection period).","Gorgas now eligible for severance on constructive termination outside CIC period; vesting provisions revised for post-Effective Date grants."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001880","json":"https://secwatch.observer/filing/0001640334-25-001880.json","markdown":"https://secwatch.observer/filing/0001640334-25-001880.md","text":"https://secwatch.observer/filing/0001640334-25-001880.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001880/0001640334-25-001880-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033425001880/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:11:08.935533+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}